Cybin (HELP) Total Liabilities (2021 - 2024)
Cybin (HELP) reported Total Liabilities of $9.5 million for Q4 2024, up 52.5% on a YoY basis from $6.2 million in Q1 2024, and up 76.23% quarter-over-quarter from $5.4 million in Q3 2024.
Cybin (HELP) Total Liabilities (2021 - 2024) Analysis & Trends
Cybin has reported Total Liabilities for 4 years, with the latest figure at $9.5 million in Q4 2024.
- For the quarter ending Q4 2024, Total Liabilities rose 52.5% year-over-year to $9.5 million; the trailing twelve-month figure through Dec 2024 stood at $9.5 million (up 52.5% YoY), and the FY2024 full-year result was $7.5 million, changed N/A from the prior year.
- Total Liabilities for Q4 2024 stood at $9.5 million, up from $5.4 million in the prior quarter.
- The five-year high for Total Liabilities was $9.5 million in Q4 2024, with the low at $3.2 million in Q4 2022.
- Historically, Total Liabilities has averaged $5.4 million across 4 years, with a median of $5.1 million in 2021.
- Annual changes were most pronounced in 2023 — Total Liabilities soared 94.05% — and 2024, when it tumbled 48.79%.
- Cybin's Total Liabilities stood at $4.8 million in 2021, then tumbled by 33.11% to $3.2 million in 2022, then soared by 94.05% to $6.2 million in 2023, then surged by 52.5% to $9.5 million in 2024.
- The last three Total Liabilities figures came in at $9.5 million (Q4 2024), $5.4 million (Q3 2024), and $3.5 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9.53 Mn |
| Sep 30, 2024 | 5.40 Mn |
| Jun 30, 2024 | 3.52 Mn |
| Mar 31, 2024 | 7.49 Mn |
| Dec 31, 2023 | 6.25 Mn |
| Sep 30, 2023 | 6.89 Mn |
| Jun 30, 2023 | 6.87 Mn |
| Feb 28, 2023 | 3.34 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Dec 31, 2021 | 4.81 Mn |
| Sep 30, 2021 | 4.82 Mn |
| Jun 30, 2021 | 5.34 Mn |
| Mar 31, 2021 | 4.74 Mn |